# The Medicines (Traditional Herbal Medicinal Products for Human Use) Regulations 2005, Paragraph 8

Extent: E+W+S+N.I.

In the Unlicensed Medicinal Products for Human Use (Transmissible Spongiform Encephalopathies) (Safety) Regulations 2003, in regulation 1 (citation, commencement and interpretation), in paragraph (2)—
(a) in the definition of “unlicensed product”—
(i) in sub-paragraph (a)(ii) after “Medicinal Products” insert “or under Regulation (EC) No. 726/2004 of the European Parliament and of the Council laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency”,
(ii) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(iii) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(b) in the definition of “the TSE Guideline” after “for human use” insert “as substituted by Commission Directive 2003/63/EC amending Directive 2001/83/EC on the Community code relating to medicinal products for human use”.

---
Source: https://www.legislation.gov.uk/uksi/2005/2750/schedule/7/paragraph/8 (the official version)
Page: https://openlegislation.uk/medicines-traditional-herbal-medicinal-products-for-human-use-regulations-2005/schedule-7/paragraph-8
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.